investors news - CANNBIT

investors news

31.08.2022

Tikkun Olam-Cannbit publishes the first midterm financial reports for 2022: The company presents a positive EBITDA with an increase in revenues and a reduction in expenses

29.08.2022

Tikun Olam - Cannbit continues to implement the strategy of penetrating the global arena An exclusive agreement for the production and export of 'Avidekel' oil, a strain rich in CBD which is researched over the world, to the UK

22.08.2022

Tikkun Olam - Cannabit will start exporting its products to Europe already in the forthcoming quarter, after obtaining from the German Ministry of Health the European Union’s GMP-EU standard for the production, export, trade and marketing of cannabis products to Europe The pharmaceutical factory for medical cannabis in accordance with the European GMP-EU standard was established in Israel

17.08.2022

Tikun Olam - Cannbit raised 18.3 million NIS in a rights issue from stakeholders, institutional investors and the company's management The proceeds of the offering are intended for the further implementation of the strategy outlined by the company and global expansion The rights issue was also attended by institutional investors, the senior management of the company, and a number of directors